In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus

被引：6
|
作者：
Kaushik, Amit [1 ]
Ammerman, Nicole C. [1 ]
Martins, Olumide [1 ]
Parrish, Nicole M. [2 ]
Nuermberger, Eric L. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2019年 / 63卷 / 06期
基金：
美国国家卫生研究院;
关键词：
Mycobacterium abscessus; omadacycline; drug susceptibility assay; eravacycline; tetracyclines; tigecycline; RAPIDLY GROWING MYCOBACTERIA; NONTUBERCULOUS MYCOBACTERIA; LUNG-DISEASE; TIGECYCLINE; EPIDEMIOLOGY; INFECTIONS; GENE;
D O I：
10.1128/AAC.00470-19
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Tigecycline is used in multidrug regimens for salvage therapy of Mycobacterium abscessus infections but is often poorly tolerated and has no oral formulation. Here, we report similar in vitro activity of two newly approved tetracycline analogs, omadacycline and eravacycline, against 28 drug-resistant clinical isolates of M. abscessus complex. Since omadacycline and eravacycline appear to be better tolerated than tigecycline and since omadacycline is also formulated for oral dosing, these tetracycline analogs may represent new treatment options for M. abscessus infections.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
    Snydman, David R.
    McDermott, Laura A.
    Jacobus, Nilda V.
    Kerstein, Kathryn
    Grossman, Trudy H.
    Sutcliffe, Joyce A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [42] In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates
    Ozger, H. Selcuk
    Cuhadar, Tugba
    Yildiz, Serap Suzuk
    Gulmez, Zehra Demirbas
    Dizbay, Murat
    Tunccan, Ozlem Guzel
    Kalkanci, Ayse
    Simsek, Husniye
    Unaldi, Ozlem
    JOURNAL OF ANTIBIOTICS, 2019, 72 (08): : 600 - 604
  • [43] Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of Mycobacterium abscessus subsp. abscessus in vitro
    Asami, Takahiro
    Aono, Akio
    Chikamatsu, Kinuyo
    Igarashi, Yuriko
    Morishige, Yuta
    Murase, Yoshiro
    Yamada, Hiroyuki
    Takaki, Akiko
    Mitarai, Satoshi
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (01): : 1 - 9
  • [44] Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis
    Diana H. Quan
    Gayathri Nagalingam
    Ian Luck
    Nicholas Proschogo
    Vijaykumar Pillalamarri
    Anthony Addlagatta
    Elena Martinez
    Vitali Sintchenko
    Peter J. Rutledge
    James A. Triccas
    Scientific Reports, 9
  • [45] Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis
    Quan, Diana H.
    Nagalingam, Gayathri
    Luck, Ian
    Proschogo, Nicholas
    Pillalamarri, Vijaykumar
    Addlagatta, Anthony
    Martinez, Elena
    Sintchenko, Vitali
    Rutledge, Peter J.
    Triccas, James A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] In Vitro Activity of Dalbavancin against Drug-Resistant Staphylococcus aureus Isolates from a Global Surveillance Program
    McCurdy, Sandra P.
    Jones, Ronald N.
    Mendes, Rodrigo E.
    Puttagunta, Sailaja
    Dunne, Michael W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) : 5007 - 5009
  • [47] In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand
    Leechawengwongs, Manoon
    Prammananan, Therdsak
    Jaitrong, Sarinya
    Billamas, Pamaree
    Makhao, Nampueng
    Thamnongdee, Nongnard
    Thanormchat, Arirat
    Phurattanakornkul, Arisa
    Rattanarangsee, Somcharn
    Ratanajaraya, Chate
    Disratthakit, Areeya
    Chaiprasert, Angkana
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (01)
  • [48] In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates
    Yamatani, Izumi
    Aono, Akio
    Fujiwara, Keiji
    Asami, Takahiro
    Kamada, Keisuke
    Morishige, Yuta
    Igarashi, Yuriko
    Chikamatsu, Kinuyo
    Murase, Yoshiro
    Yamada, Hiroyuki
    Takaki, Akiko
    Komiya, Kosaku
    Mitarai, Satoshi
    MICROBIOLOGY SPECTRUM, 2024, 12 (07): : e0008424
  • [49] Pyrosequencing for Rapid Detection of Extensively Drug-Resistant Mycobacterium tuberculosis in Clinical Isolates and Clinical Specimens
    Lin, S. -Y. Grace
    Rodwell, Timothy C.
    Victor, Thomas C.
    Rider, Errin C.
    Pham, Lucy
    Catanzaro, Antonino
    Desmond, Edward P.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (02) : 475 - 482
  • [50] Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms
    Mendes, Rodrigo E.
    Huband, Michael D.
    Streit, Jennifer M.
    Castanheira, Mariana
    Flamm, Robert K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 97 (03)
12345